In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates

This publication has 13 references indexed in Scilit:

• In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida spp
  Antimicrobial Agents and Chemotherapy, 2002
• In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of Zygomycetes
  Antimicrobial Agents and Chemotherapy, 2002
• Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000
  Antimicrobial Agents and Chemotherapy, 2002
• In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole
  Journal of Antimicrobial Chemotherapy, 2001
• In Vitro Activities of Four Novel Triazoles against Scedosporium spp
  Antimicrobial Agents and Chemotherapy, 2001
• In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literature
  Mycopathologia, 2001
• In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus and Fusarium Isolates
  Antimicrobial Agents and Chemotherapy, 2001
• In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole
  Diagnostic Microbiology and Infectious Disease, 1999
• In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi
  Journal of Antimicrobial Chemotherapy, 1998
• In Vitro Activity of a New Oral Triazole, BMS-207147 (ER-30346)
  Antimicrobial Agents and Chemotherapy, 1998